The adolescent and young adult with cancer: state of the art -- bone tumors. - Wikidata - awgldk - TriplyDB

The adolescent and young adult with cancer: state of the art -- bone tumors.

The adolescent and young adult with cancer: state of the art -- bone tumors.

http://www.wikidata.org/entity/Q38108248

about

Adoptive cell therapy for sarcoma Secreted Frizzled-Related Protein 2 (sFRP2) promotes osteosarcoma invasion and metastatic potential p21-activated kinase 7 is an oncogene in human osteosarcoma MicroRNA-503 acts as a tumor suppressor in osteosarcoma by targeting L1CAM.MicroRNA-33b suppresses migration and invasion by targeting c-Myc in osteosarcoma cells Sox2 antagonizes the Hippo pathway to maintain stemness in cancer cells S-adenosylmethionine blocks osteosarcoma cells proliferation and invasion in vitro and tumor metastasis in vivo: therapeutic and diagnostic clinical applications Aberrant Retinoblastoma (RB)-E2F Transcriptional Regulation Defines Molecular Phenotypes of Osteosarcoma.ZD6474, a new treatment strategy for human osteosarcoma, and its potential synergistic effect with celecoxib Loss of Runx2 sensitises osteosarcoma to chemotherapy-induced apoptosis.MicroRNA-224 promotes the sensitivity of osteosarcoma cells to cisplatin by targeting Rac1.Alteration of WWOX in human cancer: a clinical view.PPARγ agonists promote differentiation of cancer stem cells by restraining YAP transcriptional activity.Proteomics of osteosarcoma.Canine osteosarcoma: a naturally occurring disease to inform pediatric oncology.The immunotherapy of canine osteosarcoma: a historical and systematic review.Heat shock transcription factor 1 promotes the proliferation, migration and invasion of osteosarcoma cells.Foscan and foslip based photodynamic therapy in osteosarcoma in vitro and in intratibial mouse models.MicroRNA-124 upregulation inhibits proliferation and invasion of osteosarcoma cells by targeting sphingosine kinase 1.MicroRNA-132 inhibits cell growth and metastasis in osteosarcoma cell lines possibly by targeting Sox4.MicroRNA-196a overexpression promotes cell proliferation and inhibits cell apoptosis through PTEN/Akt/FOXO1 pathway.The tumor suppressor role of PAQR3 in osteosarcoma.How PET/MR Can Add Value For Children With Cancer.Serum microRNA-17 functions as a prognostic biomarker in osteosarcoma.Tetrahydrocurcumin induces mesenchymal-epithelial transition and suppresses angiogenesis by targeting HIF-1α and autophagy in human osteosarcoma.PAK5 overexpression is associated with lung metastasis in osteosarcoma.Paeoniflorin induces G2/M cell cycle arrest and caspase-dependent apoptosis through the upregulation of Bcl-2 X-associated protein and downregulation of B-cell lymphoma 2 in human osteosarcoma cells.ATF4 regulated by MYC has an important function in anoikis resistance in human osteosarcoma cells.

P2860

Q27009541-43CAF957-C5D5-4055-837E-00633EF9603E Q30827937-97F5F020-77A6-4A7E-AD31-10E1DA07A246 Q34430382-B32BC037-F4B4-45D8-A886-0461ECE4E369 Q34764403-59C7F8F9-956B-43FB-99C6-4B108D9D034F Q35535148-0A01A686-76E2-4899-AB77-2D7211652648 Q35601012-560246D4-73D6-4359-87A1-6C0C8BB8B236 Q35602148-D8A98A5E-6018-44CB-8B35-2B0F5F954CD4 Q36301216-BD24FD68-1CD7-4141-969A-24BB03A95D6F Q36356334-F2BD3862-18D1-4877-A46A-4EEC61DF4D64 Q36750689-F2751CD1-22D1-4078-89CB-BF1591976FF8 Q36944910-7ECCD583-AB9E-4A26-97B4-B45F2778A2C3 Q37071040-FEC6CB30-139A-4246-99DB-8CAEB690FAAD Q37641546-FB2FBF20-4C46-415A-840D-35B6393BA244 Q38198116-9617DFC4-F63B-445F-BF9E-6A124F4771A9 Q38220804-0BBDFA94-5185-4446-81FC-D8097160B39A Q38451770-4E25B4C5-508A-4B94-92B5-088A1BC8BCF6 Q38709198-D1D8DBE1-1DB3-4A86-AB2B-A2449132DC41 Q38726635-6B9FEA01-D76E-405C-AE0C-D2D6971DA64B Q38741167-8DD3A38B-E840-47AB-A8FB-9EC291CB68C2 Q38836625-ABF3354C-6C0E-4FCD-901F-0B7683EAC224 Q38867232-4E8C2677-03B7-4902-BDF6-AF0079A3922A Q38928368-E1E4FE81-395F-40DD-BC46-2B9A59D3868F Q39427334-C69C0343-84B0-433A-A287-0297597AF9F1 Q41413210-2EB91518-2698-4A2E-8BF4-FD337442EEA7 Q47107018-9C776488-83CC-43DB-B9BA-EA2699C7E315 Q49422936-8D743B2D-A835-49D2-9ECE-2FB444ED2154 Q49831544-94446FF0-78A0-431F-BF35-D6D6D83ABF67 Q53714815-DBBD4CEF-AA02-449F-B894-59D387D04EB0

P2860

The adolescent and young adult with cancer: state of the art -- bone tumors.

http://www.wikidata.org/entity/Q38108248

description

article científic

@ca

article scientifique

@fr

articol științific

@ro

articolo scientifico

@it

artigo científico

@gl

artigo científico

@pt

artigo científico

@pt-br

artikel ilmiah

@id

artikull shkencor

@sq

artículo científico

@es

name

The adolescent and young adult with cancer: state of the art -- bone tumors.

@en

type

label

The adolescent and young adult with cancer: state of the art -- bone tumors.

@en

prefLabel

The adolescent and young adult with cancer: state of the art -- bone tumors.

@en

P1433

Q38108248-29D66AE8-7D32-4FEC-A9BD-6D6A81CA1C3F

P1476

Q38108248-A9DA3140-0233-40D8-BB38-BDFF6D042254

P2093

Q38108248-634C73BC-539F-4282-B17A-D4126BB4140F

Q38108248-990715C4-3C95-4706-97D5-087F6AAEA1CD

Q38108248-EDD8AAFD-1BBC-40CF-BEB1-24E7AFA7C181

P2860

Q38108248-014EEC94-DC78-4BDD-85B1-321891A735EA

Q38108248-065724F1-6035-4BD7-991C-641A1A0E59C4

Q38108248-09CD80EA-4C72-45AE-BF8E-3426E4C8C080

Q38108248-0A2D2BC6-B97E-4EB8-B253-EBD7A1AEFD9D

Q38108248-13E611B9-06AF-445B-9EF7-9EDE74B82BAD

Q38108248-16F013A9-03F1-4ACA-8A1B-DC5FFDB9F94D

Q38108248-1892433D-EB46-4ABC-8344-0F546ADC7D43

Q38108248-20DA7DCC-CAA7-4D38-BD33-E08D12F4E488

Q38108248-21D4C62E-BE0B-45D0-93EB-419592D258EF

Q38108248-2F1CE416-03FF-4B54-B3A1-3C3D90959E7A

P2888

Q38108248-81828B98-D8B7-4D30-B365-877E1812975A

P304

Q38108248-A029BA83-2225-4B52-86E8-C3B9BC11AC46

P31

Q38108248-33C32A6D-AFC7-40D6-BFC0-992FFCDF5666

P356

Q38108248-DF35E79F-A2EE-4020-AAEE-3D0437DABC45

P433

Q38108248-61E3F560-CA39-4103-A811-FA4C173E82D2

P478

Q38108248-AF5124B2-E7F8-495C-B440-B7638753D227

P577

Q38108248-40501845-E698-4CE2-9936-E79C73D5A925

P5875

Q38108248-0841F142-449D-4FEF-95C0-4828459706E2

P6179

Q38108248-AF582B5D-5029-4175-A3D0-6B4A057783F2

P698

Q38108248-4298613F-390A-4692-871B-DE9B6355063D

P921

Q38108248-22EEDE11-9604-4D96-BD0B-27EF1FB9D388

P356

S11912-013-0321-9

P1433

Current Oncology Reports

P1476

The adolescent and young adult with cancer: state of the art -- bone tumors.

@en

P2093

Jason T Yustein

http://www.w3.org/2001/XMLSchema#string

Lisa L Wang

http://www.w3.org/2001/XMLSchema#string

Nino Rainusso

http://www.w3.org/2001/XMLSchema#string

P2860

Addition of pamidronate to chemotherapy for the treatment of osteosarcoma

Ecteinascidin 743 interferes with the activity of EWS-FLI1 in Ewing sarcoma cells

Phase II/III trial of etoposide and high-dose ifosfamide in newly diagnosed metastatic osteosarcoma: a pediatric oncology group trial.

Improvement in histologic response but not survival in osteosarcoma patients treated with intensified chemotherapy: a randomized phase III trial of the European Osteosarcoma Intergroup.

Combination of gemcitabine and docetaxel in the treatment of children and young adults with refractory bone sarcoma.

Irinotecan and temozolomide for Ewing sarcoma: the Memorial Sloan-Kettering experience.

R1507, a monoclonal antibody to the insulin-like growth factor 1 receptor, in patients with recurrent or refractory Ewing sarcoma family of tumors: results of a phase II Sarcoma Alliance for Research through Collaboration study

Phase I/II trial and pharmacokinetic study of cixutumumab in pediatric patients with refractory solid tumors and Ewing sarcoma: a report from the Children's Oncology Group

Phase II study of sequential gemcitabine followed by docetaxel for recurrent Ewing sarcoma, osteosarcoma, or unresectable or locally recurrent chondrosarcoma: results of Sarcoma Alliance for Research Through Collaboration Study 003.

Phase II study of cisplatin and oral VP16 in patients with refractory or relapsed Ewing sarcoma.

P2888

s11912-013-0321-9

P304

296-307

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S11912-013-0321-9

http://www.w3.org/2001/XMLSchema#string

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

15

http://www.w3.org/2001/XMLSchema#string

P577

2013-08-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

236924294

http://www.w3.org/2001/XMLSchema#string

P6179

1050579506

http://www.w3.org/2001/XMLSchema#string

P698

23690089

http://www.w3.org/2001/XMLSchema#string

P921